BioSpace News Archive

Getinge announces an agreement to acquire 100% of the shares in High Purity New England, Inc. a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications.

To enhance the patient experience throughout a clinical trial journey, Alcanza Clinical Research, a mission-driven investigator site network, announces a partnership with Climb, a provider of digital clinical trial solutions.

Enterin Inc. announces the acceptance by the U.S. Food and Drug Administration (FDA) of an investigator sponsored Investigational New Drug (IND) application (166532) to treat a patient with prodromal multisystem atrophy (MSA) with ENT-01.

Pinetree Therapeutics, Inc. announced the addition of Pamela A. Trail, PhD, to its Scientific Advisory Board as well as the appointment of John Majercak, PhD, as Chief Technology Officer.

According to our new research study on “Hematology Analyzers and Reagents Market to 2027 – Global Analysis and Forecast – by Product and Service, Application, and End User,” the Hematology Analyzers and Reagents Market Size was valued at US$ 7,252.54 million in 2019 and is projected to reach US$ 13,007.87 million by 2027;

The new family of patent granted by USPTO strengthens BioMark’s global intellectual property position in liquid biopsy and early cancer detection

LumaBridge, a clinical research organization dedicated to discovering, developing, and testing emerging biotechnologies related to cancer therapies, announced the appointment of Todd Lehman as Vice President and Head of Business Development.

InDex Pharmaceuticals Holding AB will hold an investor call in light of press release announcing the company’s license agreement.

Alkermes plc announced that management will participate in fireside chats at two upcoming investor conferences.

Mirion announced that Chief Executive Officer, Thomas Logan, will present at the Jefferies Healthcare Conference in New York, NY.